Characterization of Genetically Engineered Mesenchymal Stem Cells for Neurotherapeutic Applications

Begin with transgenic mouse mesenchymal stem cells—multipotent cells derived from bone marrow.

The cells are engineered to express GFP and therapeutic neurotrophic factors that support neuronal growth and survival.

Wash the cells with buffer and fix them to preserve cellular integrity.

Wash again with buffer, then add a solution to permeabilize the cell and nuclear membranes and block non-specific binding sites.

Introduce primary antibodies targeting a cell proliferation marker protein expressed exclusively in the nucleus of dividing cells.

Wash with buffer to remove unbound antibodies.

Add fluorophore-conjugated secondary antibodies targeting the primary antibodies and a DNA-binding dye to counterstain the nuclei.

Wash with buffer to remove unbound reagents.

Load the plate into the high-content screening system and capture images to detect fluorescent signals.

Expression of the cell proliferation marker indicates active cell division, suggesting the suitability of the transgenic cells for neurotherapeutic applications.

To carry out a Ki-67 cell proliferation assay, use 0.1 molar phosphate buffer to rinse the cell cultures for one minute. After repeating the wash, use 4% Paraformaldehyde, o